Eczema and the power of arthritis drugs

A new Eczema therapy has been making positive stride in controlling this skin condition by using a drug that is originally designed to treat arthritis. Eczema known by its medical term Atopic Dermatitis is a common skin conditions in newborns and sometimes continue throughout their lives into adulthoods.

This new drugs was treated to six individuals with Eczema (mid to severe cases) in a trail run. The study shows that the individuals were treated successfully. Many of them had a reduction of itchiness. What is interesting is that these individuals tried many different Eczema treatments in the past with no success. They felt more relief after the treatment and a lot happier.

The researchers believe the drug, tofacitinib citrate, were successful because Eczema could be an autoimmune disease, which is still debatable. The drug triggers an interruption in the immune response of the patient that could be causing Eczema.

The focus now is to possibly to do more trials and evaluating the long terms effects of using tofacitinib citrate. The early study is promising and maybe one day it will be used officially in treating Eczema.